Process Analytical Technology Market Assessment, By Product [Analyzers, Sensors and Probes, Samplers, Software and Services], By Technology [Spectroscopy, Chromatography, Capillary Electrophoresis, Particle Size Analysis, Others], By Monitoring Method [In

Process Analytical Technology Market Assessment, By Product [Analyzers, Sensors and Probes, Samplers, Software and Services], By Technology [Spectroscopy, Chromatography, Capillary Electrophoresis, Particle Size Analysis, Others], By Monitoring Method [In-Line, At-Line, On-Line, Off-Line], By End-user [Pharmaceutical Manufacturers, Biopharmaceutical Manufacturers, Contract Research Organizations (CROs)/CDMOs], By Region, Opportunities and Forecast, 2017-2031F

Global respiratory care devices market is projected to witness a CAGR of 7.07% during the forecast period 2024-2031, growing from USD 23.15 billion in 2023 to USD 39.98 billion in 2031.

The rise in respiratory diseases, the geriatric population, and increased pollution rates are some factors propelling the global respiratory care devices market. Advances in technology, rising investment in healthcare, and the prevalence of chronic obstructive pulmonary disease (COPD) as well as asthma also drive the demand. COVID-19 underlined the need for respiratory support, investments, and global awareness in respiratory care solutions. This has marked significant growth in the global respiratory care devices market during the COVID-19 pandemic.

Respiratory care devices are used to diagnose, monitor, and treat increasingly common respiratory disorders caused by pollution, aging populations, and lifestyle factors. These devices include ventilators, nebulizers, and oxygen concentrators, and they are all crucial for supporting respiratory function and delivering patient care within hospitals and home settings. Increased awareness about respiratory health has made these devices more in demand, especially since the COVID-19 pandemic highlighted the requirement for balanced and reliable support related to respiration. Technological advancements with portable, user-friendly devices expand their utilization beyond clinical settings into the home environment for chronic patients to manage symptoms over time. Respiratory care devices are pivotal in effectively managing respiratory diseases while reducing hospital admissions and improving healthcare efficiency worldwide.

Improving product offerings through the innovation of new technology makes companies create substantial value for customers. The growth of the respiratory care devices market fuels overall demand and market expansion. For instance, in August 2024, Oxymed, a brand of Medequip Healthcare Solutions Pvt Ltd., launched the SleepEasy Auto CPAP device. The company’s portfolio also includes i-series PAPs; it has the most advanced technology, including the FlowSens algorithm, at significantly better comfort and at much lower prices than the international brands can offer. These products are CE-certified and accompanied by a quality warranty. This expansion in the product offerings will bring better respiratory care to more individuals in India, improving customers' satisfaction and the number of orders in the market.

Strategic Investments in Respiratory Care Devices

Strategic investments in the respiratory care devices market have been developing breakthrough technologies for personalized treatments, increasing the accuracy of diagnostics, and increasing patient compliance. Investments are made in advanced ventilators that will eventually provide a more effective management system for complicated respiratory diseases and significantly reduce complications arising from the conditions. Continuous monitoring devices critical to managing chronic respiratory diseases and those used to detect real-time changes in lung functions are also other investment areas showing large-scale focus. Besides, investments in miniaturization improve patient comfort and enable higher compliance with long-term treatments. Strategic partnerships allow innovative solutions to redefine care standards and contribute to a constantly better outcome for respiratory diseases.

For instance, in January 2023, Telesair, Inc. received Series A funding of USD 22 million from Pasaca Capital, Inc. to launch an ICU-focused Bonhawa Respiratory Humidifier in the market and design a new product to provide safer and quicker patient discharge.

Rising Air Pollution Levels Promotes the Market

The increase in air pollution levels is driving the escalation of respiratory diseases, such as asthma and breathing difficulties, thereby gaining popularity for respiratory care equipment. As a response, the government is introducing various measures to strengthen respiratory healthcare, including contributing to research in diagnostic as well as therapeutic apparatus. These measures are strengthening the respiratory care market as air pollution-linked health concerns rise, further underlining the urge for proper respiratory care solutions. For instance, in June 2024, HP Ghosh Hospital in Salt Lake City, Calcutta, launched Chest Tree, an initiative for good respiratory health. This project shows the hospital's commitment to advancing respiratory care using the most up-to-date technology and specialized medical staff. The Chest Tree visually maps all types of respiratory conditions, including COPD, asthma, lung cancer, and other sleep disorders, for easier comprehension of the facilities offered. This thus allows patients to better engage with and understand the treatment options, thereby upgrading awareness.

Rising Awareness of Respiratory Care

With the growing awareness of respiratory health issues, more people are now focusing on their respiratory well-being; hence, there is an increasing demand for respiratory care devices. Nowadays, people are more conscious of air pollution's impact on their lives, leading to more adoption of products like portable oxygen concentrators and non-invasive ventilators. Therefore, growing awareness is driving the market further towards innovation in home-care solutions as consumers look for easily accessible solutions with friendlier interfaces that can help them cope with asthma. Considering this increased demand for effective personalized respiratory care solutions, manufacturers are innovating to expand their offerings.

For instance, in May 2023, Cipla Limited introduced the 'Tuffies' campaign to increase awareness of respiratory care in children across India, especially patient groups with asthma. This would influence the market for respiratory care devices with increased awareness and demand for effective solutions for asthma management in children. Moreover, in October 2022, AirPhysio Pty Ltd partnered with Apollo Hospitals Group and Medsmart and launched its respiratory devices in India. This partnership is set to increase the awareness and demand for these innovative products in India.

COPD Application Segment to Lead the Growth of Market Due to Rising Patient Population

The COPD segment leads in the market for respiratory care devices primarily due to the increased incidence of chronic obstructive pulmonary disease. Improvement in technology and continuous innovation ensures the development of advanced devices to improve patient results. Partnerships of leading healthcare companies with device manufacturers promote this trend, thus providing a boost to the development and distribution of innovative solutions. Such efforts result in higher adoption of respiratory care devices for COPD. The strategic focus on COPD management becomes one of the key drivers for market growth and addresses the needs of patients with such conditions.

For instance, in March 2023, the University of California, Davis, in collaboration with Propeller Health, launched a remote monitoring program for patients. The program consists of sensors, a mobile app, and personalized support to track medication usage and respiration, which might then be integrated with UC Davis's electronic health records for enhanced patient care. The program can be expanded to other health systems under the University of California, enhancing chronic disease management, especially COPD.

North America to be in the Dominating Region

North America leads the global respiratory care devices market due to a combination of factors. The high prevalence of respiratory conditions like asthma, COPD, and even sleep apnea in the region is a major factor driving demand for more advanced respiratory devices. Based on CDC data published in 2023, asthma affects 7.7% of Americans and is more prevalent in adults, at 8.0%, and females at 9.7%. Of the reported 24.9 million affected, 60% of the adults and 44% of the children experience uncontrolled asthma. In addition, an increasing awareness of respiratory health issues through various organizations and government efforts has further led to expanding this market. In the United States, a program called ""Healthy People 2030, ""initiated by the U.S. Department of Health and Human Services, promotes respiratory health. The emergence of key regional players further hastens the innovation and accessibility of advanced devices. In addition, the well-established healthcare infrastructure, growing healthcare expenditures, and rising adoption of home healthcare solutions in North America further favor the region's leadership in the global marketplace.

Future Market Scenario (2024-2031F)

Key drivers for future growth in respiratory care devices are the growing incidence of chronic respiratory diseases, advancements in technology, and the need for home healthcare solutions. Advancements in miniaturization of devices and integration into the digital health platform will expand patient availability, further propelling market growth.

In October 2024, Inspira-Technologies OXY B.H.N. LTD. introduced disposable blood oxygenation kit for all types of life support machines compatible with INSPIRA ART devices.

This innovation will help boost the efficiency of hospitals in maintaining compatibility with cardio-pulmonary bypass machines. This launch is expected to spur growth in the respiratory care devices market by providing cost-effective and versatile solutions for better patient care.

In April 2023, OxyGo HQ Florida, LLC launched a new product for the portable oxygen concentrator, the OxyHome 5L Stationary Concentrator, which is aptly designed to provide constant flow with up to 5L per minute. This oxygen supply is highly recommended for home use. The launch would have a significant impact on the market for respiratory care devices, increasing readily available home-based oxygen therapy options and therefore demand for convenient and user-friendly respiratory solutions in the next few years.

Key Players Landscape and Outlook

Companies have been productively tailoring services to the specific needs and preferences of patients to build up market positions. They are integrating advanced technologies such as AI and IoT to improve efficiency regarding devices as well as outcomes for patients. Another strategy is to enter new international markets to enhance the base of customers. Companies associate themselves with healthcare providers and technology firms through collaborative partnerships in innovation and wider offerings. These strategies help firms increase their market reach and drive growth in the forecast period.

In February 2024, ResMed Inc launched in the United States AirCurve 11 branded series of bilevel-positive airway pressure devices. Bilevel machines, utilizing the AirSense 11 platform, are designed to help move patients with difficulties using CPAP to other comfort and convenience devices. The AirCurve 11 VAuto responds to the patient's breathing patterns with comfort that will produce better compliance of the patient. With Philips having exited the market because of the massive recall, ResMed will face an even firmer grip on the respiratory care device market through superior and reliable solutions.